ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2301

Trend of Osteoporosis and Osteoporotic Fragility Fractures Among Select Autoimmune Rheumatologic Diseases: Results from National Inpatient Sample

Rashmi Dhital1, Theresa Lynn2, Pragya Shrestha3, Sijan Basnet4, Prakash Paudel5, Priyadarshani Sharma2, Paras Karmacharya6 and Dilli Poudel7, 1Reading Hospital-Tower Health System, West Reading, PA, 2Reading Hospital, West Reading, PA, 3Internal medicine, Reading Hospital-Tower Health System, West Reading, PA, 4Internal Medicine, Reading Hospital, West Reading, PA, 5Internal Medicine, Berkshire Medical Center, Pittsfield, MA, 6Division of Rheumatology, Mayo Clinic, Rochester, MN, 7Internal Medicine, Reading Hospital-Tower Health System, WEST READING, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: fractures and osteoporosis, Rheumatologic Conditions

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatologic diseases (RDs) have been associated with an increased risk of osteoporosis (OP) and osteoporotic fractures, however, most patients do not receive diagnosis and adequate treatment. The aim of our study was to study the prevalence of OP and osteoporotic fractures in relation to RDs.

Methods:

We used National Inpatient Sample (2000-2014) to identify hospitalizations ≥18 years of age with OP and osteoporotic fractures and excluded fractures due to other etiologies. We studied the yearly trends of OP and osteoporotic fractures as well as compared the trends among hospitalizations with or without RDs in terms of Annual Percentage Change (APC).

Results:

OP was noted to have an increasing trend from 2000 – 2009 (APC=5.81, p<0.05) with a decline thereafter (APC=- 3.88, p <0.05). In contrast, osteoporotic fracture showed an initial downward trend from 2000-2010 (APC=-7.31, p<0.05), followed by a slowly rising trend (APC=2.0, p=NS) (Figure 1). The trends were similar in groups with or without RDs (Figure 2). RDs had higher odds of OP [ORs 2.58 (95 % CI 2.55 – 2.60), p<0.001] and osteoporotic fractures [OR 1.28 (95% CI 1.25 -1.31), p<0.001] (Table 1).

Conclusion:

RDs were associated with increased OP and osteoporotic fractures; the pathogenesis includes disease-related (chronic inflammation) and treatment-related (glucocorticoid induced) factors. Decreasing trend was noted along with a halt in a previously declining fracture rates. The noted decrease in OP might represent a true decline due to better prevention, but may also be due to decreased screening and subsequent detection. Also, if the decreased trend was due to better prevention, one would expect osteoporotic fractures to decrease as well. Potential explanations include inadequate screening per guidelines, suboptimal treatment and decreasing patient compliance, which have also been documented in many prior studies.

In conclusion, primary and secondary prevention measures for OP have been underutilized by both physicians and patients alike, although several possibilities exist. Awareness of this is vital to increase physician prescribing practices and patient compliance.

 

Table 1: Logistic regression analyses for prevalence of osteoporosis and osteoporotic fragility fracture in hospitalizations with any rheumatologic diseases

Unadjusted  OR

Adjusted*  OR

Osteoporosis

3.64 (95% CI 3.60-3.68), p< 0.001

2.58 (95% CI 2.55-2.60),  p< 0.001

Osteoporotic fragility #

1.09 (95% CI 1.06-1.11), p< 0.001

1.28 (95% CI 1.25-1.31), p<0.001

* adjusted for age, sex, race, obesity, smoking, obesity, charlson comorbidity index, steroid use


Disclosure: R. Dhital, None; T. Lynn, None; P. Shrestha, None; S. Basnet, None; P. Paudel, None; P. Sharma, None; P. Karmacharya, None; D. Poudel, None.

To cite this abstract in AMA style:

Dhital R, Lynn T, Shrestha P, Basnet S, Paudel P, Sharma P, Karmacharya P, Poudel D. Trend of Osteoporosis and Osteoporotic Fragility Fractures Among Select Autoimmune Rheumatologic Diseases: Results from National Inpatient Sample [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/trend-of-osteoporosis-and-osteoporotic-fragility-fractures-among-select-autoimmune-rheumatologic-diseases-results-from-national-inpatient-sample/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trend-of-osteoporosis-and-osteoporotic-fragility-fractures-among-select-autoimmune-rheumatologic-diseases-results-from-national-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology